SCHL heads into its July 16 earnings print with short sellers retreating, options traders leaning bullish, and the CEO selling into strength — a three-way tension that defines the week's setup.
The most notable shift in positioning is the steady unwinding of short interest. Bears have trimmed exposure by nearly 16% over the past month, with SI % of FF falling to 7.9% from around 11.4% in late May. That pullback has been broadly consistent — short shares have declined from roughly 2.3 million at the start of June to just under 1.9 million today. The borrow market loosened further this week, with availability jumping to 286% — well above the 52-week trough of 107% — meaning there are nearly three times as many shares available to borrow as are currently shorted. Cost to borrow has ticked up 36% over the week to 0.79%, but remains firmly in low-cost territory. The ORTEX short score has also drifted lower, from 64.4 on June 24 to 60.4 today, reflecting the softer short-side conviction. Positioning looks like orderly covering rather than a squeeze.
Options tell an even more directional story. The put/call ratio has collapsed to 0.31 — about a full standard deviation below its 20-day average of 0.71 — meaning call volume is running more than three times put volume. That's near the 52-week low of 0.14 and a dramatic reversal from the 1.2 PCR readings that persisted throughout most of June. Options traders have turned decisively more optimistic into the print.
The Street is cautious rather than constructive. B. Riley Securities raised its price target to $42 this morning, maintaining a Neutral rating. At $45.26, SCHL is already trading above that target — a notable discrepancy that points to limited upside in analyst models even after the upgrade. The factor scores reinforce that caution: EPS surprise ranks in just the 2nd percentile of the universe, meaning the company has a history of missing estimates, and the short score rank of 11 flags meaningful bearish relative positioning even as the absolute short interest declines.
Insider activity adds another layer of ambiguity. CEO Peter Warwick sold 8,345 shares on July 1 at $46.83, pocketing nearly $391,000 — his second sale in two months, following a smaller disposal in May. The Chief Accounting Officer sold $394,000 worth in late March. Net insider activity over the past 90 days runs to roughly $472,000 in net selling. None of these trades are enormous in the context of the float, but the pattern of executives selling into the recent price recovery is worth noting ahead of results.
The March earnings print provides a useful reference point. The stock surged 11.6% the day after reporting and extended gains to 16.9% over the following five sessions — a sharp positive reaction that likely contributed to the recent short covering. With the next print eight days away, the question is whether the combination of a low PCR, retreating short interest, and a stock already above the analyst target means the optimism is already in the price.
See the live data behind this article on ORTEX.
Open SCHL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
